Arabic Arabic English English French French German German
dark

Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy

Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, announced that it has filed its 13th new provisional patent application and has advanced the build-out of its digital therapeutics strategy. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Brooklyn ImmunoTherapeutics Welcomes Jay Sial as Chief Administrative Officer

Next Post

MOH: Precautionary Measures to Be Followed by Pilgrims

Related Posts
Total
0
Share